CNS Pharmaceuticals Inc CNSP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11/28/22 EST
5.01quote price arrow down-0.04 (-20.43%)
Volume
570,087
52 week range
0.16 - 5.01
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close5.01
  • 52 Week High5.01
  • 52 Week High Date11/28/22
  • 52 Week Low0.16
  • 52 Week Low Date10/31/22

Key Stats

  • Market Cap200.683M
  • Shares Out40.03M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change-76.21

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close5.01
  • 52 Week High5.01
  • 52 Week High Date11/28/22
  • 52 Week Low0.16
  • 52 Week Low Date10/31/22
  • Market Cap200.683M
  • Shares Out40.03M
  • 10 Day Average Volume0.09M
  • Dividend-
  • Dividend Yield-
  • Beta1.31
  • YTD % Change-76.21

RATIOS/PROFITABILITY

  • EPS (TTM)-10.40
  • P/E (TTM)-0.48
  • Fwd P/E (NTM)-31.33
  • EBITDA (TTM)-12.545M
  • ROE (TTM)-143.65%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.47%

EVENTS

  • Earnings Date03/01/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CNS Pharmaceuticals Inc

 

Profile

MORE
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing a pipeline of anti-cancer drug candidates for the treatment of primary and metastatic cancers of the brain and central nervous system. The Company's lead drug candidate, Berubicin, is a novel anthracycline and the first anthracycline to appear to cross the blood-brain barrier. Berubicin is in development for the treatment of a number of serious brain and central nervous system (CNS) oncology...
John Climaco Esq.
Chairman of the Board, Chief Executive Officer
Christopher Downs CPA
Chief Financial Officer
Address
2100 West Loop S Ste 900
Houston, TX
77027-3522
United States

Top Peers

SYMBOLLASTCHG%CHG
SLNO
Soleno Therapeutics Inc
1.04-0.04-3.70%
NBSE
NeuBase Therapeutics Inc
0.23-0.0102-4.2465%
DRMA
Dermata Therapeutics Inc
0.625-0.0067-1.0569%
GLMD
Galmed Pharmaceuticals Ltd
0.32+0.02+6.6663%
ADIL
Adial Pharmaceuticals Inc
0.2681-0.0119-4.25%